Using WhatsApp chats to understand a new approach to HIV testing in children.
Published in Healthcare & Nursing
Improving HIV testing for children and adolescents is vitally important, because children and adolescents experience a disproportionate amount of HIV-related illness and death compared to adults. Although children and adolescents aged up to 19 years old were only 7% of the global population living with HIV in 2021, they represented 17% of HIV-related deaths. This is due, in part, to late diagnosis of HIV.
A new approach to finding undiagnosed children living with HIV, known as index-linked testing, has been recommended by the World Health Organisation to improve diagnosis rates. Index-linked testing involves targeting of HIV testing to children of people living with HIV (known as indexes). This focused approach has the potential to find more children living with HIV and be more cost-effective than blanket testing approaches.
The “Bridging the Gap in HIV Testing and Care for Children in Zimbabwe” (B-GAP) study evaluated index-linked HIV testing for children aged between two and 18 years old at nine primary care clinics, covering both rural and urban areas. People living with HIV in a household with one or more children of unknown HIV status, or with a known HIV negative result more than 6 months ago, were eligible to take part in the study. Those who consented to have children tested could choose either a test at the clinic, a test at home delivered by a community healthcare worker (HCW), or a test at home delivered by a caregiver using an oral HIV self-test. B-GAP provided an opportunity to examine implementation in-depth, so lessons could be learned for future roll-out.
The B-GAP team kept in touch via two long-running WhatsApp chats, one for the whole field team, and the other for the rural areas only. We used those WhatsApp chats, as well as field team logs, meeting minutes, and incident reports, to identify barriers and facilitators to scale-up of index-linked testing. Data from each source was analysed thematically.
The WhatsApp chats deepened our understanding of implementation. In the chats, the team often offered more comprehensive opinions on successes and challenges than in other sources. For example, one chat had detailed discussion on difficulties coordinating with partner organisations who were delivering HIV testing of children in the community. This clarified the underlying reasons why these challenges were occurring, such as differences in aims between the partner organisations and the research team, as well as resource constraints faced by partner organisations. The chats also provided a real-time and dynamic account of events, such as stock-outs of HIV test kits, over time.
However, WhatsApp chats required more effort to analyse than the other sources. As the chats were an informal record, sometimes it was challenging to work out what researchers were referring to in their messages. Unlike with the other sources, the team presumed readers had prior knowledge of what was being discussed, making it difficult for an outsider to follow the conversation. Moreover, sometimes researchers met face-to-face or communicated using other technology, which led to sudden jumps in the topics being covered in the chats.
Nonetheless, through analysing the WhatsApp chats and other sources, we identified a range of challenges to index-linked testing for children. These are illustrated in the flow diagram to the right. Some challenges were recognised barriers to provision of many forms of HIV testing, such as stock-outs of HIV test kits, difficulties reaching clinics, and stigma around HIV. However, we also identified some unexpected challenges, such as indexes sending someone else to the clinic on their behalf, and a lack of familiarity with oral HIV testing, which resulted in low uptake. As index-linked HIV testing for children is used more widely it will be critical to find ways to ensure these challenges can be overcome.
The WhatsApp chats gave us valuable insight into the barriers and facilitators of index-linked HIV testing. It is important to consider newer technologies and social media alongside traditional sources of data to fully capture the complexity of implementation of public health interventions. By doing so, we can more effectively address barriers to delivery of interventions and ultimately improve health outcomes.
Read more about the B-GAP study and its findings in the following publications:
- Delivery of index-linked HIV testing for children: learnings from a qualitative process evaluation of the B-GAP study in Zimbabwe
- Comparison of index-linked HIV testing for children and adolescents in health facility and community settings in Zimbabwe: findings from the interventional B-GAP study
- Addressing the challenges and relational aspects of index-linked HIV testing for children and adolescents: insights from the B-GAP study in Zimbabwe
- Feasibility and Accuracy of HIV Testing of Children by Caregivers Using Oral Mucosal Transudate HIV Tests
Katherine is a PhD student at Imperial College London. Her PhD focuses on the links between HIV, mental health, and quality of life in sub-Saharan Africa.
Follow the Topic
-
BMC Infectious Diseases
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With collections, you can get published faster and increase your visibility.
High-threat pathogens and outbreak response
BMC Infectious Diseases welcomes submissions to our Collection on High-threat pathogens and outbreak response.
High-threat pathogens are infectious agents with the capacity to cause severe public health crises, demanding immediate and concerted responses. Characterized by their potential for rapid transmission and substantial morbidity and mortality, these pathogens necessitate vigilant management strategies encompassing robust surveillance, early detection, and effective containment measures.
This Collection aims to provide a platform for the dissemination of cutting-edge research, strategies, and best practices in the field of infectious disease management, with a particular focus on high-threat pathogens.
This Collection seeks to address the global challenges posed by emerging infectious diseases, pandemics, and outbreaks that have the potential to cause significant morbidity and mortality. We encourage researchers from diverse disciplines to participate and contribute their expertise to this Collection. Contributions can include, but are not limited to, the following:
Epidemiology of high-threat pathogens
Outbreak preparedness and planning for early warning and risk reduction
Rapid diagnostics and surveillance technologies
Vaccines and therapeutics development
Global health security and policy
Community engagement and risk communication
International collaboration and governance
This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.
All manuscripts submitted to this journal, including those submitted to Collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Sep 18, 2025
Sepsis: pathogenesis, diagnosis, and treatment
BMC Infectious Diseases is calling for submissions to our Collection on Sepsis: pathogenesis, diagnosis, and treatment. Sepsis, a life-threatening condition resulting from the body's extreme response to infection, remains a leading cause of morbidity and mortality worldwide. Bloodstream infections, a common trigger for sepsis, can lead to severe complications, including septic shock and multiple organ failure. The Sepsis-3 definition has refined our understanding of this complex syndrome, emphasizing the importance of early recognition and timely intervention. Despite advances in diagnostic techniques and therapeutic strategies, sepsis continues to pose significant challenges in clinical practice, necessitating ongoing research to improve patient outcomes.
Advancing our collective understanding of sepsis is crucial for developing effective prevention and treatment strategies. Recent advances have included the identification of novel biomarkers for early diagnosis, the refinement of the Sequential Organ Failure Assessment (SOFA) score for risk stratification, and the exploration of targeted therapeutics. These developments have the potential to enhance clinical decision-making and improve survival rates. However, the complexity of sepsis demands further investigation into its pathophysiology, the role of host factors, and the impact of emerging pathogens, including fungal infections. Continued research in this area may lead to groundbreaking discoveries in personalized medicine approaches for sepsis management, including tailored therapeutic interventions based on individual patient profiles. Additionally, advancements in technology, such as artificial intelligence and machine learning, could revolutionize early detection and monitoring of sepsis, ultimately improving patient outcomes and reducing healthcare costs.
This Collection aims to enhance understanding and improve clinical practices in sepsis and bloodstream infections management. Key topics of interest for submission include, but are not limited to:
Biomarkers for sepsis diagnosis
Therapeutics in septic shock management
Fungal sepsis and its implications
SOFA score and organ dysfunction assessment
Multiple organ failure in sepsis patients
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
Publishing Model: Open Access
Deadline: Jun 30, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in